Welcome to the Society of Immunotherapy of Cancer.

Nunc augue leo ultrices quis. Cursus dui pellentesque in odio ac. Nec est sit nibh lectus adipiscing. Aliquam ornare platea hendrerit congue molestie nulla ultrices.

Latest Content

Targets for Cancer IO: A Deep Dive Series

Recommended text length for body of 4-5 lines. Pellentesque malesuada sagittis mi quis accumsan. Nullam ac ullamcorper erat. Nam eros erat, malesuada mollis dolor et, dictum lacinia tortor. Fill distribute line link underline.

Learn More

Latest Content

Targets for Cancer IO: A Deep Dive Series

Recommended text length for body of 4-5 lines. Pellentesque malesuada sagittis mi quis accumsan. Nullam ac ullamcorper erat. Nam eros erat, malesuada mollis dolor et, dictum lacinia tortor. Fill distribute line link underline.

Learn More

Latest Content

Targets for Cancer IO: A Deep Dive Series

Recommended text length for body of 4-5 lines. Pellentesque malesuada sagittis mi quis accumsan. Nullam ac ullamcorper erat. Nam eros erat, malesuada mollis dolor et, dictum lacinia tortor. Fill distribute line link underline.

Learn More

SITC Programs

Recommended text length for body of 4-5 lines. Sit in turpis blandit elementum ridiculus vitae proin egestas amet. Pretium arcu diam ac in facilisis lorem pulvinar nulla.

Enduring Materials

Recommended text length for body of 4-5 lines. Sit in turpis blandit elementum ridiculus vitae proin egestas amet. Pretium arcu diam ac in facilisis lorem pulvinar nulla.

Membership Benefits

Recommended text length for body of 4-5 lines. Sit in turpis blandit elementum ridiculus vitae proin egestas amet. Pretium arcu diam ac in facilisis lorem pulvinar nulla.

Join the Discussion

Connect with industry experts, share insights and access exclusive resources.

Maecenas diam arcu, aliquam non egestas ac, imperdiet at velit. Aenean vulputate ullamcorper ligula, eleifend suscipit mi efficitur nec. Vestibulum viverra leo nec purus hendrerit accumsan.

Login Now

RE: Welcome to the SITC Online community!

Keegan Mager in Community 17 days ago

Journal for
Immunotherapy of Cancer

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Read the Journal

Ignite the SITC Sparkathon

Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.

Support SITC

Egestas pharetra enim diam justo morbi aliquam massa iaculis. Lacinia et netus elementum nisl faucibus enim eu.

Recent News & Publications

Save the date 2024

SITC’s 39th Annual Meeting & Pre-Conference Programs in Houston, TX.

Maecenas diam arcu, aliquam non egestas ac, imperdiet at velit. Aenean vulputate ullamcorper ligula, eleifend suscipit mi efficitur nec. Vestibulum viverra leo nec purus hendrerit accumsan.

Learn More


Find out what SITC can do for you.

Quisque condimentum eros facilisis enim sollicitudin, in consectetur mauris iaculis. In bibendum, mi in porta fringilla, sapien erat porta elit, in tempus enim dolor sed neque.

Become a Member